Gerd Meds
Pharmaceutical manufacturer Orexo has announced that its patent for a new medication to treat gastroesophageal reflux disease has been approved in Europe. The new medication combines two acid-reflux drugs to stop the production of stomach acid and to prevent it from being released. The patent is pending in America.
Read moreMore information on "Gerd Meds"
From Our Experts
When Meds Make A Meal: RA & GERD
There are so many bottles of medication sitting on my kitchen side counter that I have no doubt my poor stomach feels as if it is... Read more »
The Difference Between Gastritis and GERD
By definition gastritis is inflammation of the stomach lining (gastro = stomach, it is = inflammation). For years, I thought gastritis and... Read more »
Dr. Eisner Answers Your GERD Questions
I have acid reflux and I am concerned about undergoing anesthesia for an upcoming procedure. Am I at increased risk of aspiration? While... Read more »
Dr. Eisner Answers your GERD Questions: GERD & Marijuana Link?
Could marijuana smoking be the cause of GERD? The effect of marijuana on the symptoms of gastroesophageal reflux disease is... Read more »
From Our Sources
Most GERD sufferers take more than one med
A new survey has found that forty percent of the patients who take daily medication to control their acid reflux experience breakthrough symptoms.... Read more »
GERD ups risk of laryngeal cancer, but meds help
A new study has added to evidence that people with chronic acid reflux have an increased risk of developing laryngeal cancer. The study, reported in... Read more »
New GERD treatment enters Phase I trials
Drugmaker Pfizer has started Phase I clinical trials for its new gastroesophageal reflux disease (GERD) medication. The... Read more »
Finding the Right Acid Reflux (GERD) Medication for Your Baby
Copyright Pediatric Adolescent Gastroesophageal Reflux Assocation (www.reflux.org). This document is medically reviewed and used with ... Read more »
FDA delays review of new heartburn med
The U.S. Food and Drug Administration (FDA) has delayed their review of the experimental proton-pump inhibitor TAK-390MR. The medication, which was... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
